Heron Therapeutics (HRTX) Research & Development (2016 - 2025)
Historic Research & Development for Heron Therapeutics (HRTX) over the last 14 years, with Q3 2025 value amounting to $3.5 million.
- Heron Therapeutics' Research & Development fell 2228.44% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year decrease of 4433.28%. This contributed to the annual value of $16.7 million for FY2024, which is 5736.85% down from last year.
- As of Q3 2025, Heron Therapeutics' Research & Development stood at $3.5 million, which was down 2228.44% from $2.9 million recorded in Q2 2025.
- Heron Therapeutics' Research & Development's 5-year high stood at $42.1 million during Q1 2022, with a 5-year trough of -$13.7 million in Q4 2022.
- Moreover, its 5-year median value for Research & Development was $8.8 million (2023), whereas its average is $14.6 million.
- Per our database at Business Quant, Heron Therapeutics' Research & Development plummeted by 14759.84% in 2022 and then soared by 15676.25% in 2023.
- Quarter analysis of 5 years shows Heron Therapeutics' Research & Development stood at $28.9 million in 2021, then crashed by 147.6% to -$13.7 million in 2022, then skyrocketed by 156.76% to $7.8 million in 2023, then crashed by 59.27% to $3.2 million in 2024, then increased by 9.19% to $3.5 million in 2025.
- Its Research & Development stands at $3.5 million for Q3 2025, versus $2.9 million for Q2 2025 and $2.3 million for Q1 2025.